Richard Aranda - 25 Oct 2021 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Medical Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
25 Oct 2021
Net transactions value
-$29,118
Form type
4
Filing time
26 Oct 2021, 16:58:47 UTC
Previous filing
22 Jun 2021
Next filing
10 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale $29,118 -2,377 -1.1% $12.25* 217,432 25 Oct 2021 Direct F1
holding GOSS Common Stock 2,539 25 Oct 2021 By family trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.